ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,394,979 | +105740.6% | 54,598 | +18.8% | 0.09% | +14.1% |
| Q2 2023 | $1,318 | -16.1% | 45,971 | -29.8% | 0.08% | -18.8% |
| Q1 2023 | $1,570 | +37.2% | 65,516 | -2.8% | 0.10% | +35.2% |
| Q4 2022 | $1,144 | -99.9% | 67,435 | +11.7% | 0.07% | +20.3% |
| Q3 2022 | $895,000 | -7.9% | 60,363 | -2.3% | 0.06% | -1.7% |
| Q2 2022 | $972,000 | -39.3% | 61,761 | +4.0% | 0.06% | -29.4% |
| Q1 2022 | $1,601,000 | -10.2% | 59,385 | +23.3% | 0.08% | -3.4% |
| Q4 2021 | $1,783,000 | +24.3% | 48,170 | +60.5% | 0.09% | +17.3% |
| Q3 2021 | $1,434,000 | +114.7% | 30,013 | +52.1% | 0.08% | +108.3% |
| Q2 2021 | $668,000 | – | 19,737 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |